Key result
Among 17 sporadic odontogenic myxomas, 2 harbored PRKAR1A mutations and 7 of the remaining 15 showed decreased PRKAR1A protein expression, suggesting its down-regulation is involved in pathogenesis.
Observational (n=17)
PRKAR1A down-regulation may be involved in the pathogenesis of sporadic odontogenic myxomas, representing the first myxomatous lesion found to harbor somatic PRKAR1A sequence changes.
Answers are grounded in this paper and cite their sources.
PRKAR1A down-regulation may drive sporadic odontogenic myxomas; leaves open its diagnostic or therapeutic relevance pending validation.
Odontogenic myxomas are rare benign neoplasms affecting the jaw. Myxomas of bones and other sites occur as part of Carney complex (CNC), a multiple neoplasia syndrome caused by mutations in the PRKAR1A gene, which codes for the regulatory subunit of protein kinase A (PKA). In the present study, 17 odontogenic myxomas from patients without CNC were screened for PRKAR1A mutations and PRKAR1A protein expression by immunohistochemistry (IHC). Mutations of the coding region of the PRKAR1A gene were identified in 2 tumors; both these lesions showed no or significantly decreased immunostaining of PRKAR1A in the tumor compared to that in the surrounding normal tissue. One mutation (c.725C>A) led to a nonconservative amino acid substitution in a highly conserved area of the gene (A213D); the other was a single base-pair deletion that led to a frameshift (del774C) and a stop codon 11 amino acids downstream of the mutation site; both tumors were heterozygous for the respective mutations. Of the remaining tumors, 7 of the 15 without mutations showed almost no PRKAR1A in the tumor cells, whereas IHC showed that the protein was abundant in nontumorous cells. We concluded that PRKAR1A may be involved by its down-regulation in the pathogenesis of odontogenic myxomas caused by mutations and/or other genetic mechanisms. Of the sporadic, nonfamilial tumors associated with PRKAR1A mutations, the odontogenic type was the first myxomatous lesion found to harbor somatic PRKAR1A sequence changes.
No takes yet. Share an insight, caveat, or question.
Perdigão et al. (2005) conducted an observational in Odontogenic myxomas (n=17). PRKAR1A mutations and protein expression was evaluated on PRKAR1A mutations and protein expression. Among 17 sporadic odontogenic myxomas, 2 harbored PRKAR1A mutations and 7 of the remaining 15 showed decreased PRKAR1A protein expression, suggesting its down-regulation is involved in pathogenesis.
Synapse has enriched 10 related papers. Consider them for comparative context: